Insider Holders & Insider Ownership - CytomX Therapeutics Inc. (CTMX)

List of insiders holdings for CytomX Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
See Explanation of Responses
2024-11-14 16:26:32 8,089,795
0
8,089,795 Form 13G
2 SHANNON TIMOTHY M
Director
2016-12-01 14:35:01 448
3,244,381
3,244,829 Form 4
3 McCarthy Sean A.
CEO
2025-03-20 16:34:40 995,195
93,158
1,088,353 Form 4
4 Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT CO
Deerfield Special Situations Fund L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
Possible Member of 10% Group
10% Owner
2015-10-14 12:37:56 946,024
0
946,024 Form 13G
5 Hadley Harbor Master Investors (Cayman) L.P.
10% Owner
2015-10-14 15:36:21 749,055
0
749,055 Form 4
6 Goeltz II Robert C.
Chief Financial Officer
2017-05-16 16:57:43 323,325
0
323,325 Form 4
7 BELVIN MARCIA
SVP, Chief Scientific Officer
2025-03-20 16:31:34 248,636
0
248,636 Form 4
8 THIRD ROCK VENTURES LP
Third Rock Ventures GP L.P.
TRV GP LLC
LEVIN MARK J
STARR KEVIN P
TEPPER ROBERT I
10% Owner
2019-02-13 16:07:03 227,653
0
227,653 Form 13G
9 Ogden Christopher
Chief Financial Officer
2025-03-20 16:33:49 201,026
0
201,026 Form 4
10 Chu Yu-Waye
Chief Medical Officer
2025-03-20 16:32:56 135,725
0
135,725 Form 4
11 Landau Jeffrey B
Chief Business Officer
2024-08-22 18:01:51 119,056
7,680
126,736 Form 4
12 ROWLAND LLOYD A
General Counsel
2025-03-20 16:32:22 120,594
0
120,594 Form 4
13 Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
2020-02-19 18:41:18 120,000
0
120,000 Form 4
14 RAY DEBANJAN
Chief Financial Officer
2019-01-29 18:57:09 90,000
0
90,000 Form 4
15 HUMPHREY RACHEL
Chief Medical Officer
2019-01-29 19:00:03 90,000
0
90,000 Form 4
16 LADD CYNTHIA J
Senior VP and General Counsel
2017-01-27 13:52:15 84,000
0
84,000 Form 4
17 Peterson Amy C.
EVP, Chief Development Officer
2023-03-20 18:43:26 58,433
0
58,433 Form 4
18 Campoy Carlos
Chief Financial Officer
2023-03-20 18:43:33 38,224
0
38,224 Form 4
19 Young Matthew P.
Director
2024-05-17 17:36:18 38,000
0
38,000 Form 4
20 Ashworth Alan
Director
2024-05-17 17:31:09 38,000
0
38,000 Form 4
21 Gilbert Halley E
Director
2024-05-17 17:32:25 38,000
0
38,000 Form 4
22 Jones Elaine V
Director
2024-05-17 17:33:14 38,000
0
38,000 Form 4
23 Meyers James R
Director
2024-05-17 17:34:02 38,000
0
38,000 Form 4
24 Mohindru Mani
Director
2024-05-17 17:34:38 38,000
0
38,000 Form 4
25 Su Zhen
Director
2024-05-17 17:36:07 38,000
0
38,000 Form 4
26 Knifsend Robin
Principal Accounting Officer
2020-02-21 12:34:43 34,000
0
34,000 Form 4
27 HANNAH ALISON L.
Chief Medical Officer
2022-07-21 16:09:25 31,898
0
31,898 Form 4
28 GLUCK FREDERICK W
Director
2022-06-17 16:05:38 25,000
0
25,000 Form 4
29 SCARLETT JOHN A
Director
2021-06-17 18:46:39 20,000
0
20,000 Form 4
30 Fuchs Charles S.
Director
2020-06-17 17:06:48 20,000
0
20,000 Form 4
31 Huh Hoyoung
Director
2018-06-15 17:51:36 14,000
0
14,000 Form 4
32 McCourt Marion
Director
2017-06-22 13:58:17 14,000
0
14,000 Form 4
33 Exter Neil
Director
2017-06-22 13:56:58 14,000
0
14,000 Form 4
34 Canaan IX L.P.
Canaan Partners IX LLC
Director
2017-07-07 08:40:32 0
0
0 Form 13G